2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 130 filers reported holding 2SEVENTY BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $67 | -28.0% | 17,357 | +0.2% | 0.00% | – |
| Q1 2024 | $93 | +25.7% | 17,329 | -0.4% | 0.00% | – |
| Q4 2023 | $74 | +8.8% | 17,403 | -0.3% | 0.00% | – |
| Q3 2023 | $68 | -60.9% | 17,462 | +1.5% | 0.00% | – |
| Q2 2023 | $174 | -1.1% | 17,210 | -0.3% | 0.00% | – |
| Q1 2023 | $176 | -29.0% | 17,256 | -34.8% | 0.00% | – |
| Q4 2022 | $248 | -99.9% | 26,466 | +0.0% | 0.00% | -100.0% |
| Q3 2022 | $385,000 | +11.0% | 26,465 | +0.6% | 0.00% | – |
| Q2 2022 | $347,000 | +25.3% | 26,299 | +62.2% | 0.00% | – |
| Q1 2022 | $277,000 | -33.4% | 16,216 | -0.2% | 0.00% | – |
| Q4 2021 | $416,000 | – | 16,244 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 684,996 | $9,885,521 | 8.20% |
| Madison Avenue Partners, LP | 1,199,832 | $11,242,426 | 1.99% |
| Newtyn Management, LLC | 882,134 | $8,265,596 | 1.71% |
| AlphaCentric Advisors LLC | 180,000 | $1,686,600 | 1.67% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $13,201 | 1.48% |
| Casdin Capital, LLC | 1,850,000 | $17,334,500 | 1.34% |
| CHI Advisors LLC | 333,252 | $3,122,571 | 0.83% |
| Birchview Capital, LP | 59,833 | $561 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 250,000 | $2,342,500 | 0.34% |
| EcoR1 Capital, LLC | 1,143,494 | $10,714,539 | 0.33% |